BioFire Diagnostics Receives FDA Clearance for FilmArray 2.0 System | GenomeWeb

NEW YORK (GenomeWeb) – BioMérieux today announced that its subsidiary BioFire Diagnostics has received US Food and Drug Administration clearance and CE-IVD marking for the FilmArray 2.0 system.

The PCR-based platform has higher throughput, processing up to 175 samples per day, and a smaller footprint, the firm said in a statement. It will be commercially available by the end of March.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.